Carregando...
Post-translational modifications of EZH2 in cancer
Enhancer of zeste homolog 2 (EZH2), as a main component of Polycomb Repressive Complex 2, catalyzes histone H3K27me3 to silence its target gene expression. EZH2 upregulation results in cancer development and poor prognosis of cancer patients. Post-translational modifications (PTMs) are important bio...
Na minha lista:
| Publicado no: | Cell Biosci |
|---|---|
| Principais autores: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7731458/ https://ncbi.nlm.nih.gov/pubmed/33308321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00505-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|